Drugs / BJBR-BCMA-006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06983951 | Feb 2025 → Sep 2027 expected | AL amyloidosis | Beijing Boren Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BJBR-BCMA-006 | “Research drug name: Targeted BCMA Autologous CART Cell Injection Drug code: BJBR-BCMA-006 Administration method: single intravenous injection” NCT06983951 ↗ |
| Known as | Targeted BCMA Autologous CART Cell Injection | “Research drug name: Targeted BCMA Autologous CART Cell Injection Drug code: BJBR-BCMA-006 Administration method: single intravenous injection” NCT06983951 ↗ |
| Modality | Cell therapy | “The cell product used in this study is a targeted BCMA autologous CART cell injection.” NCT06983951 ↗ |
| Route | Intravenous | “single intravenous injection” NCT06983951 ↗ |